» Articles » PMID: 36204633

Medical Cannabis Dimethyl Ether, Ethanol and Butane Extracts Inhibit the Growth of Bacteria and Dermatophytes Causing Common Skin Diseases

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Oct 7
PMID 36204633
Authors
Affiliations
Soon will be listed here.
Abstract

Cannabis preparations are gaining popularity among patients with various skin diseases. Due to the lack of scientific evidence, dermatologists remain cautious about their prescriptions. So far, only a few studies have been published about the effects of high-potency cannabis extracts on microorganisms (especially dermatophytes) causing skin problems that affect more than 25% of the worldwide population. Even though, the high-potency cannabis extracts prepared by cold extraction are mostly composed of non-psychoactive tetrahydrocannabinolic acid (THCA) and only low amount of THC, their use in topical treatment can be stigmatized. The antimicrobial and antifungal activity of two high potent cannabis strains extracted by three solvents traditionally or currently used by cannabis users (ethanol; EtOH, butane; BUT, dimethyl ether; DME) was investigated by broth dilution method. The chemical profile of cannabis was determined by high-performance liquid chromatography with ultraviolet detection and gas chromatography with mass spectrometer and flame ionization detector. The extraction methods significantly influenced chemical profile of extracts. The yield of EtOH extracts contained less cannabinoids and terpenes compared to BUT and DME ones. Most of the extracts was predominantly (>60%) composed of various cannabinoids, especially THCA. All of them demonstrated activity against 18 of the 19 microorganisms tested. The minimal inhibitory concentrations (MICs) of the extracts ranged from 4 to 256 μg/mL. In general, the bacteria were more susceptible to the extracts than dermatophytes. Due to the lower content of biologically active substances, the EtOH extracts were less effective against microorganisms. Cannabis extracts may be of value to treat dermatophytosis and other skin diseases caused by various microorganisms. Therefore, they could serve as an alternative or supportive treatment to commonly used antibiotics.

Citing Articles

Inhibitory Potential of Cannabis Biomass Extracts on Livestock-Associated Staphylococcal and Streptococcal Pathogens.

Paulova T, Malikova L, Lanzoni D, Taubner T, Malik M, Houdkova M Microorganisms. 2025; 13(2).

PMID: 40005797 PMC: 11857943. DOI: 10.3390/microorganisms13020432.


Cannabis sativa L.: A comprehensive review on legislation, decriminalization, phytochemistry, antimicrobial activity, and safety.

Dalli M, Azizi S, Azghar A, Saddari A, Benaissa E, Ben Lahlou Y J Food Drug Anal. 2024; 31(3):408-435.

PMID: 39666278 PMC: 10629910. DOI: 10.38212/2224-6614.3471.


Anti-staphylococcal activity of soilless cultivated cannabis across the whole vegetation cycle under various nutritional treatments in relation to cannabinoid content.

Malikova L, Malik M, Pavlik J, Ulman M, Pechouckova E, Skrivan M Sci Rep. 2024; 14(1):4343.

PMID: 38383569 PMC: 10881570. DOI: 10.1038/s41598-024-54805-3.


Study of Cannabis Oils Obtained from Three Varieties of and by Two Different Extraction Methods: Phytochemical Characterization and Biological Activities.

Pino S, Espinoza L, Jara-Gutierrez C, Villena J, Olea A, Diaz K Plants (Basel). 2023; 12(9).

PMID: 37176831 PMC: 10180737. DOI: 10.3390/plants12091772.

References
1.
Cintosun A, Lara-Corrales I, Pope E . Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases. Clin Drug Investig. 2020; 40(4):293-304. DOI: 10.1007/s40261-020-00894-7. View

2.
Politi M, Peschel W, Wilson N, Zloh M, Prieto J, Heinrich M . Direct NMR analysis of cannabis water extracts and tinctures and semi-quantitative data on delta9-THC and delta9-THC-acid. Phytochemistry. 2007; 69(2):562-70. DOI: 10.1016/j.phytochem.2007.07.018. View

3.
Singh A, Masih A, Khurana A, Kumar Singh P, Gupta M, Hagen F . High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene. Mycoses. 2018; 61(7):477-484. DOI: 10.1111/myc.12772. View

4.
van Klingeren B, ten Ham M . Antibacterial activity of delta9-tetrahydrocannabinol and cannabidiol. Antonie Van Leeuwenhoek. 1976; 42(1-2):9-12. DOI: 10.1007/BF00399444. View

5.
Zajicek J, Hobart J, Slade A, Barnes D, Mattison P . Multiple sclerosis and extract of cannabis: results of the MUSEC trial. J Neurol Neurosurg Psychiatry. 2012; 83(11):1125-32. DOI: 10.1136/jnnp-2012-302468. View